tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with fluorouracil in 1 studies
| Studies (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Trials (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Recent Studies (post-2010) (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
|---|---|---|---|---|---|
| 111 | 0 | 29 | 45,562 | 9,307 | 14,663 |
| Protein | Taxonomy | tyrosyl-isoleucyl-glycyl-seryl-arginine (IC50) | fluorouracil (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
| Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
| Aromatase | Homo sapiens (human) | 0.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubey, PK; Singodia, D; Vyas, SP | 1 |
1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and fluorouracil
| Article | Year |
|---|---|
Liposomes modified with YIGSR peptide for tumor targeting.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Drug Delivery Systems; Endothelium, Vascular; Fluorouracil; Humans; Liposomes; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Oligopeptides | 2010 |